Pharmaceuticals, Biotechnology and Life Sciences
KEYTRUDA is First Anti-PD-1 Therapy to be Approved in Multiple Tumor Types in China KENILWORTH, N.J.–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24MRK&src=ctag" target="_blank"gt;$MRKlt;/agt; lt;a…
Designation Based on Phase 2 SPRINT Trial in Pediatric Patients with NF1 Plexiform Neurofibromas Selumetinib Is a MEK 1/2 Inhibitor…
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies…
Two posters are being presented at the AACR Annual Meeting in Atlanta, GeorgiaExicure’s TLR9 agonist shows activation of NK cells…
DUBLIN–(BUSINESS WIRE)–The “Global Industrial Microbiological QC Market: Focus on Technology Trends, Application, Regulatory Framework, and Competitive Mapping Analysis and Forecast:…
DUBLIN–(BUSINESS WIRE)–The “Primary Progressive Multiple Sclerosis (PPMS) – Pipeline Insight, 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. The…
DUBLIN–(BUSINESS WIRE)–The “Hyperuricemia – Pipeline Insight, 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. The report offers comprehensive insights…
DUBLIN–(BUSINESS WIRE)–The “Hypersomnia – Pipeline Insight, 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. The report offers comprehensive Insight…
DUBLIN–(BUSINESS WIRE)–The “H3N2 Infection – Pipeline Insight, 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. The report offers comprehensive…
DUBLIN–(BUSINESS WIRE)–The “Hematopoietic Stem Cell Transplantation – Pipeline Insight, 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. The report…